Rising incidence of papillary thyroid carcinoma in Germany

被引:0
|
作者
Radespiel-Troeger, M. [1 ]
Batzler, W. U. [2 ]
Holleczek, B. [3 ]
Luttmann, S. [4 ]
Pritzkuleit, R. [5 ]
Stabenow, R. [6 ]
Urbschat, I. [7 ]
Zeissig, S. R. [8 ]
Meyer, M. [1 ]
机构
[1] Bevolkerungsbezogenes Krebsregister Bayern, D-91054 Erlangen, Germany
[2] Epidemiol Krebsregister Nordrhein Westfalen, Munster, Germany
[3] Saarland Krebsregister, Saarbrucken, Germany
[4] Leibniz Inst Pravent Forsch & Epidemiol BIPS GmbH, Bremer Krebsregister, Bremen, Germany
[5] Inst Krebsepidemiol eV, Krebsregister Schleswig Holstein, Registerstelle, Lubeck, Germany
[6] Gemeinsames Krebsregister Lander Berlin, Brandenburg, Mecklenburg Vorpommern, Sachsen Anhalt & Freistaaten Sachsen & Thuringen, Berlin, Germany
[7] OFFIS Care GmbH, Epidemiol Krebsregister Niedersachsen, Registerstelle, Oldenburg, Germany
[8] Tumorzentrum Rheinland Pfalz eV, Vertrauensstelle, Krebsregister Rheinland Pfalz, Mainz, Germany
关键词
Thyroid; Cancer; Carcinoma; Incidence; Registry; CANCER INCIDENCE; INCREASING INCIDENCE; UNITED-STATES; RISK-FACTORS; EXPOSURE; ENGLAND; SWEDEN; ADULTS; TRENDS;
D O I
10.1007/s00103-013-1884-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The incidence of thyroid cancer (TC), a rare malignancy, has strongly risen in recent decades. Possible causes of this rise include increasing diagnostic activity, nuclear tests after World War II, and the Chernobyl disaster. This article presents the time trends of TC incidence between 2003 and 2008 in Germany according to histological tumor type and sex, and provides a description of TC incidence according to districts (Kreise) and sex in Germany. Data on persons newly diagnosed with thyroid cancer (ICD-10 code, C73) between 2003 and 2008 were obtained from the Center of Cancer Registry Data at the Robert Koch Institute. Official population and mortality data were used. Age-specific and age-standardized incidence rates (ASIR) were calculated according to sex and tumor histology. Between 2003 and 2008, the ASIR of TC rose from 2.7 to 3.4 (men) and from 6.5 to 8.9 (women) per 100,000 per year. This rise can be almost completely attributed to the rising incidence of papillary TC. The steepest rise in frequency was observed in TNM-T1 tumors. A positive north-south gradient of TC incidence was found. The cause of the marked rise of TC incidence in recent decades is unknown. The positive north-south gradient of the TC incidence may possibly be attributed in part to long-standing differences of iodine intake between different German regions. An epidemiological study of the possible causes of the rising TC incidence and of the regional differences of TC incidence in Germany is recommended.
引用
收藏
页码:84 / 92
页数:9
相关论文
共 50 条
  • [31] Incidence and Mortality Risk Spectrum Across Aggressive Variants of Papillary Thyroid Carcinoma
    Ho, Allen S.
    Luu, Michael
    Barrios, Laurel
    Chen, Irene
    Melany, Michelle
    Ali, Nabilah
    Patio, Chrysanta
    Chen, Yufei
    Bose, Shikha
    Fan, Xuemo
    Mallen-St Clair, Jon
    Braunstein, Glenn D.
    Sacks, Wendy L.
    Zumsteg, Zachary S.
    [J]. JAMA ONCOLOGY, 2020, 6 (05) : 706 - 713
  • [32] The Incidence of Papillary Thyroid Carcinoma (PTC) in Nodules Not Biopsied by Fine Needle Aspiration
    Atieh, M. K.
    Fons, M. E.
    Barkan, G. A.
    Mehrotra, S.
    Wafai, R.
    Salhadar, A.
    Wojcik, E.
    Kapur, U.
    [J]. MODERN PATHOLOGY, 2011, 24 : 83A - 83A
  • [33] The incidence and features of Delphian lymph node involvement in patients with papillary thyroid carcinoma
    Alibakhshi, Abbas
    Sheikhi, Saman
    Yazd, Seyed Mostafa Meshkati
    Ardekani, Ali
    Ranjbar, Keivan
    Shahriarirad, Reza
    [J]. BMC SURGERY, 2022, 22 (01)
  • [34] RISING INCIDENCE OF SMALL SIZE PAPILLARY THYROID CANCERS WITH NO CHANGE IN DISEASE-SPECIFIC SURVIVAL IN FINNISH THYROID CANCER PATIENTS
    Hakala, T.
    Kellokumpu-Lehtinen, P.
    Kholova, I.
    Holli, K.
    Huhtala, H.
    Sand, J.
    [J]. SCANDINAVIAN JOURNAL OF SURGERY, 2012, 101 (04) : 301 - 306
  • [35] Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma
    Teng, Lianghong
    Deng, Wanglong
    Lu, Junliang
    Zhang, Jing
    Ren, Xinyu
    Duan, Huanli
    Chuai, Shannon
    Duan, Feidie
    Gao, Wei
    Lu, Tao
    Wu, Huanwen
    Liang, Zhiyong
    [J]. ONCOTARGET, 2017, 8 (13) : 22023 - 22033
  • [36] Familial papillary thyroid carcinoma
    Kostoglou-Athanassiou, I
    Georgakopoulou, G
    Christodoulou, I
    Kourkoulou, M
    Tournis, S
    Pappas, A
    Grech, J
    Kaldrymidis, P
    [J]. PROCEEDINGS OF THE 12TH INTERNATIONAL CONGRESS OF ENDOCRINOLOGY, 2004, : 1031 - 1035
  • [37] Papillary thyroid carcinoma - An overview
    Al-Brahim, Nabeel
    Asa, Sylvia L.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2006, 130 (07) : 1057 - 1062
  • [38] Papillary thyroid carcinoma on sonography
    Li, Quan-shui
    Chen, Sheng-hua
    Xiong, Hua-hua
    Xu, Xiao-hua
    Li, Zhen-zhou
    Guo, Guo-qiang
    [J]. CLINICAL IMAGING, 2010, 34 (02) : 121 - 126
  • [39] Papillary Thyroid Carcinoma Variants
    Lloyd R.V.
    Buehler D.
    Khanafshar E.
    [J]. Head and Neck Pathology, 2011, 5 (1) : 51 - 56
  • [40] Multifocal Papillary Thyroid Carcinoma
    de Cap, Maximiliano Ramia
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 155 (06) : 913 - 913